Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection; Viral, Enterovirus”

462 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 462 results

Not applicableActive Not RecruitingNCT06922474
What this trial is testing

Molecular Epidemiology of Enteroviruses Detected at the Virology Laboratory of Brest University Hospital During the Period 2018-2024: Retrospective Analysis of an Atypical Meningitis Epidemic in 2024 (BrEcho9Men)

Who this might be right for
Enterovirus InfectionsMeningitis, ViralMeningitis Enterovirus+1 more
University Hospital, Brest 270
Not applicableLooking for participantsNCT07358910
What this trial is testing

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who this might be right for
DengueChikungunyaZika Virus Infection+55 more
Institut Pasteur du Cambodge 10,000
Large-scale testing (Phase 3)Study completedNCT01507857
What this trial is testing

An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine

Who this might be right for
Hand, Foot and Mouth Disease
Sinovac Biotech Co., Ltd 10,077
Testing effectiveness (Phase 2)Study completedNCT00031512
What this trial is testing

Pleconaril Enteroviral Sepsis Syndrome

Who this might be right for
Enterovirus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 61
Post-approval studies (Phase 4)Study completedNCT03274102
What this trial is testing

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines

Who this might be right for
Hand, Foot and Mouth Disease
Sinovac Biotech Co., Ltd 780
Testing effectiveness (Phase 2)Study completedNCT03241030
What this trial is testing

Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial

Who this might be right for
HerpanginaGingivostomatitisHand, Foot and Mouth Disease
University of Texas at Austin 102
Post-approval studies (Phase 4)Study completedNCT04220515
What this trial is testing

Inactivated Poliomyelitis Vaccine Made From Sabin Strain

Who this might be right for
Poliomyelitis
Institute of Medical Biology, Chinese Academy of Medical Sciences 49,731
Not applicableStudy completedNCT01697280
What this trial is testing

Polio NID and Routine EPI Integration Trial Pakistan

Who this might be right for
Polio
Aga Khan University 4,560
Large-scale testing (Phase 3)Study completedNCT01086423
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine

Who this might be right for
TetanusPoliomyelitisAcellular Pertussis+2 more
GlaxoSmithKline 985
Large-scale testing (Phase 3)Study completedNCT01287949
What this trial is testing

Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older

Who this might be right for
DiphtheriaTetanusPoliomyelitis+1 more
Sanofi Pasteur, a Sanofi Company 342
Testing effectiveness (Phase 2)Study completedNCT01940250
What this trial is testing

Magnesium Sulphate for Severe Hand, Foot and Mouth Disease in Vietnam

Who this might be right for
Hand, Foot and Mouth Disease
Oxford University Clinical Research Unit, Vietnam 26
Early research (Phase 1)Study completedNCT04264598
What this trial is testing

Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine

Who this might be right for
Polio
Jiangsu Province Centers for Disease Control and Prevention 100
Post-approval studies (Phase 4)Study completedNCT00534885
What this trial is testing

Safety, Immunogenicity, and Immune Persistence Study of an Inactivated Hepatitis A Vaccine

Who this might be right for
Hepatitis A
Sinovac Biotech Co., Ltd 400
Post-approval studies (Phase 4)Study completedNCT01094171
What this trial is testing

Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia

Who this might be right for
Poliomyelitis
GlaxoSmithKline 400
Post-approval studies (Phase 4)Study completedNCT04091880
What this trial is testing

Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine

Who this might be right for
Enterovirus InfectionsInfluenza
China National Biotec Group Company Limited 1,134
Large-scale testing (Phase 3)Study completedNCT00432042
What this trial is testing

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

Who this might be right for
VaricellaMeaslesMumps+7 more
Merck Sharp & Dohme LLC 955
Not applicableStudy completedNCT01554930
What this trial is testing

Effectiveness and Safety of Chinese Medicine to Treat Hand, Foot, and Mouth Disease

Who this might be right for
Hand, Foot, and Mouth Disease
Jiangxi Qingfeng Pharmaceutical Co. Ltd. 230
Post-approval studies (Phase 4)Study completedNCT02601040
What this trial is testing

Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines

Who this might be right for
Hepatitis A
Jiangsu Province Centers for Disease Control and Prevention 13,500
Large-scale testing (Phase 3)Study completedNCT03239496
What this trial is testing

Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV

Who this might be right for
Poliomyelitis
Fidec Corporation 773
Large-scale testing (Phase 3)Study completedNCT02428491
What this trial is testing

Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 354
Next Page